Podcasts about Catalysis

Mike Hicks' connection to investing in mid-market companies dates back to 1994, when he worked at the EBRD, contributing to the creation of the first private equity fund in Romania. After overseeing a joint venture between Creditanstalt Investment Bank and Advent International, he developed a keen interest in enhancing investor-management interactions, dedicating over 20 years to this pursuit.In 2010, Mike founded Catalysis, following several years of leading a similar practice at Grant Thornton. With the support of skilled colleagues, he has managed over 375 projects since the company's inception, Mike advocates the importance of coachability and partnership in navigating the complex landscape of mid-market firms.In this episode, Dominic explores the myths and realities of private equity as Mike dismantles common misconceptions about management and investment partnerships. Highlighting the nuanced dynamics between investors and business leaders, he explains that in smaller companies, collaboration often trumps the fear of management changes. Discover The Role of Private Equity in Business Growth: Private equity plays a crucial role in providing funding for businesses, particularly those lacking tangible assets for traditional bank loans, such as tech companies. It serves as an alternative to the UK's shrinking bank funding market by offering equity, facilitating business growth, and providing management teams a pathway to personal wealth.Misconceptions About Private Equity: Management teams often face misconceptions about private equity investment. Some assume operations will continue unchanged, while others fear losing control to investors. In truth, investors aim to add value and collaborate for improvements without seizing control of the business.Team and Organisational Alignment: Aligning the management team's capabilities with the business's needs is crucial. This match depends on the business model's complexity, market conditions, and growth goals. Businesses often require guidance to optimise their leadership teams to effectively meet these demands.Governance and Strategy in Management: Effective governance should balance strategy formulation and operational execution without overwhelming management. Boards should prioritise maintaining this balance to ensure alignment with value creation rather than focusing solely on financial oversight. Keeping boards small and focused helps avoid operational inefficiencies.Mistakes in Scaling Businesses with Private Equity: Common mistakes in scaling businesses post-private equity deal include neglecting due diligence insights, misunderstanding strategy, underestimating organisational inertia, confusing change activity with results, hastily making key personnel decisions, and suffering from unbalanced governance. Avoiding these pitfalls is essential for the success of private-equity-backed ventures.Higher Multiples with Demonstrated Scalability: Businesses that can demonstrate scalability, such as sustainable growth and robust operational capacity, are more likely to attract higher multiples and favourable responses from investors during deals, highlighting the importance of long-term strategic planning.Book recommendations:Rory Sutherland - Alchemy

Emily Swaney is the Senior Director of the Lean Promotion Office at OhioHealth, a 16-hospital healthcare system based out of Columbus, Ohio. She has a degree in Operations Management and Marketing complimented by 14 years of experience in lean facilitation. Emily's passion is creating a culture of problem solvers, and she has partnered with the Shingo Institute, ISE, and Catalysis in publishing articles, webinars, and podcasts on this topic. Emily is a coach for the Ohio State University's Masters of Business in Operational Excellence program and is also the owner of Advance Lean Consulting LLC, which focuses on partnering with organizations early in their process improvement journey through custom development and support of Lean roadmaps.Link to claim CME credit: https://www.surveymonkey.com/r/3DXCFW3CME credit is available for up to 3 years after the stated release dateContact CEOD@bmhcc.org if you have any questions about claiming credit.

Dr. John Toussaint, Catalysis' Executive Chairman of the Board and Steve Shortell, Co-Founder of the Center for Lean Engagement and Research (CLEAR) at the University of California – Berkley, follow-up with us on the discussion they started on episode 85 about their article “The Better Care Plan: A Blueprint for Improving America's Healthcare System” and the coalition workgroups that have started up.

Episode 149: "Ascension Catalysis For Money and You”

Some debate that synthetic organic chemistry strategies have become stale, but Dr. Todd Hyster of Princeton University's Hyster Lab disagrees.Todd fell in love with organic chemistry early in his education, but it wasn't until he got turned on to enzyme catalysis that he found his true calling. He's built a career using engineered enzymes to facilitate chemical transformations that would otherwise not be possible. Specifically, he and his team focus on photo-enzymatic catalysis where they use a combination of light and engineered proteins to drive new chemical transformations.Join us to learn about his work, the methods involved, and the types of transformations being accomplished, which is beyond enantioselective synthesis, by the way. This stimulating conversation delves into the tactical and philosophical aspects of the synthetic chemistry, enzyme catalysis, and even the realities of academic funding and industry collaboration. Related episodes: Season 3, Ep.2: Making impossible moleculesSeason 2, Ep.3: Rethinking catalysisBonus content!Access bonus content curated by this episode's guest by visiting www.thermofisher.com/chemistry-podcast for links to recent publications, podcasts, books, videos and more.View the video of this episode on www.thermofisher.com/chemistry-podcast.A free thank you gift for our listeners! Request your free Bringing Chemistry to Life t-shirt on our episode website.Use code BCTLisn3R in September, and cHeMcas+ng in October We read every email so please share your questions and feedback with us! Email helloBCTL@thermofisher.com

Die Brainwashed - Radio Edition ist eine einstündige Show mit Musik von den Künstlern und Labels auf Brainwashed.com. 1. Blonde Redhead, "Melody Experiment" (Sit Down for Dinner) 2023 Section1 2. Joshua Hill and Micaela Tobin, "Fade Away" (Tent Music) 2023 Whited Sepulchre 3. Euglossine, "Pollinator" (Bug Planet Is the Current Timeline) 2023 Hausu Mountain 4. The Bug, "Sickness(Slowly dying)" (Machine 2) 2023 Pressure 5. Aereogramme, "The Black Path" (Sleep and Release) 2003 Chemikal Underground 6. Merzbow, "CATalysis No 3" (CATalysis) 2023 Elevator Bath 7. Fugazi, "Returning the Screw" (In On the Kill Taker) 1993 Dischord 8. Lankum, "Newcastle" (False Lankum) 2023 Rough Trade 9. Fabiano do Nascimento, "Babel" (Das Nuvens) 2023 Leaving 10. Drawing Virtual Gardens, "Be aware there is a goat hidden in the trees" (22:22) 2023 Lost Tribe Sound 11. Lusine, "Zero to Sixty (ft. Sarah Jaffe)" (Long Light) 2023 Ghostly 12. Theodore Cale Schafer, "See You Soon" (Trust) 2023 Students of Decay * Eine Sendung vom 29. Juli 2023. # Brainwashed - Radio Edition Email podcast at brainwashed dot com to say who you are; what you like; what you want to hear; share pictures for the podcast of where you're from, your computer or MP3 player with or without the Brainwashed Podcast Playing; and win free music! We have no tracking information, no idea who's listening to these things so the more feedback that comes in, the more frequent podcasts will come. You will not be put on any spam list and your information will remain completely private and not farmed out to a third party. Thanks for your attention and thanks for listening. * http://brainwashed.com

Most of us don't grow up across the street from a chemistry building or know from an early age that we want to be a scientist, but Alan Dyke, VP of Business Development for ProChem, Inc. (CTO of Boulder Scientific Company at the time of the interview) did and became a chemist. Dr. Alan Dyke, former colleague, and friend of Paolo's, shares his career path and discusses the history and current state of the field of catalysis. With a father that taught university-level chemistry, and a brother in the field, it may not be surprising that Alan Dyke became a chemist, but it is surprising is that he's considered to be the outcast of the family for choosing a commercial career instead of taking an academic route. But, as he'll passionately reveal, there are upsides to choosing a non-academic career. Join us for a wonderful conversation where Paolo and Alan recount their shared history and the evolution of the catalysis field over recent decades. They discuss the evolution of homogeneous cross-coupling, biocatalysis, metathesis, and metallocene chemistry. Application of catalysis to fields as varied as pharmaceuticals and polymers is discussed, along with sustainability and other trends and dynamics in the field. Overcome your activation energy and join us!Related episodes: Season 1, Ep.2: Reinventing plastics, one reaction at a time Season 2, Ep.1: Chemistry: a modern American dreamSeason 2, Ep.6: The charm of the forgotten elements Bonus content!Access bonus content curated by this episode's guest by visiting www.thermofisher.com/chemistry-podcast for links to recent publications, podcasts, books, videos and more.View the video of this episode on www.thermofisher.com/chemistry-podcast. A free thank you gift for our listeners! Visit the episode website and request your free Bringing Chemistry to Life t-shirt.Use Podcast Code:  laBcheM in March or sc13nc3 in April We read every email so please share your questions and feedback with us! Email helloBCTL@thermofisher.com About Your HostPaolo Braiuca grew up in the North-East of Italy and holds a PhD in Pharmaceutical Sciences from nearby esteemed University of Trieste, Italy. He developed expertise in biocatalysis during his years of post-doctoral research in Italy and the UK, where he co-founded a startup company. With this new venture, Paolo's career shifted from R&D to business development, taking on roles in commercial, product management, and marketing. He has worked in the specialty chemicals, biotechnology, and pharmaceutical markets in Germany and the UK, where he presently resides. He is currently the Director of Global Market Development in the Laboratory Chemicals Division at Thermo Fisher Scientific™ which put him in the host chair of the Bringing Chemistry to Life podcast. A busy father of four, in what little free time he has, you'll find him inventing electronic devices with the help of his loyal 3D-printer and soldering iron. And if you ask him, he'll call himself a “maker” at heart.

Die Themen in den Wissensnachrichten: +++ Make-up vorm Sport ist schlecht für die Haut +++ Mikroplastik könnte Ausbreitung von Krebs begünstigen +++ Anthropozän-Zeitalter erstmal doch nicht ausgerufen +++**********Weiterführende Quellen zu dieser Folge:Influence of cosmetic foundation cream on skin condition during treadmill exercise, Journal of Cosmetic Dermatology, 06.03.2024Microplastics role in cell migration and distribution during cancer cell division, Chemosphere, April 2024Complete electrocatalytic defluorination of perfluorooctane sulfonate in aqueous solution with nonprecious materials, Journal of Catalysis, March 2024Environmental radiation exposure at Chornobyl has not systematically affected the genomes or chemical mutagen tolerance phenotypes of local worms, PNAS, 05.03.2024**********Ihr könnt uns auch auf diesen Kanälen folgen: Tiktok und Instagram.

In this podcast episode, MRS Bulletin's Elizabeth Wilson interviews Manos Mavrikakis from the University of Wisconsin–Madison about his group's theoretical work on real-world industrial catalytic conditions. It is often assumed that most catalyst surface atoms stay in place during a reaction, firmly bonded to their metal neighbors. However, Mavrikakis's theoretical framework shows that under industrial reaction conditions, a surprising amount of metal–metal bond breaking is likely happening during catalytic reactions. This framework predicts that under reaction conditions, some adsorbed molecules have the strength to scavenge metal atoms from the catalyst particle, causing metal atoms to be ejected to a different spot on the metal surface. Bonds between metal atoms in certain geometries such as kinks can also break, even without adsorbed species, due to heat. However, the presence of reaction molecules may greatly increase the frequency of these events. The ejected metal atoms can then move around on the surface, collect together into groups such as trimers, tetramers, hexamers, or larger ensembles, forming entirely new types of active sites. This work was published in Science.

Support this show http://supporter.acast.com/moorethanjustapodcast. Hosted on Acast. See acast.com/privacy for more information.

Bringing Chemistry to Life is as much about the people behind the science as it is about the science itself. We've been remiss in sharing a bit more about the creator and host! In this unique episode we flip the script and move Paolo from the host chair to the guest chair to hear his story. From Paolo's childhood memories watching his father fix electronics and his dreams of being in the NBA, he chats about developing into a skilled bioorganic chemist, working in biocatalysis and his contributions to international study programs. He describes the “God-like” powers that organic chemistry gave him, manipulating matter and creating things that didn't exist before and how this led to becoming an R&D leader in a startup. Our protagonist's story takes a turn when he discovers and becomes enamored with the “dark side” of science finding success in sales, product management, and product marketing roles, where we find him today. The origin story of Bringing Chemistry to Life is uncovered, fulfilling his aspiration of being a podcast host while keeping him connected to great science and market trends. Join us to meet Paolo, your host, learn what he gets from hosting the podcast, and what he hopes listeners get from it!Related episodes: Season 1, Ep.1: Human milk — its a matter of chemistry (aka The Start of it All) Season 4, Ep.2: Paul Anastas — The father of green chemistry (aka A Dream Come True)  Bonus content!Access bonus content curated by this episode's guest by visiting www.thermofisher.com/chemistry-podcast for links to recent publications, podcasts, books, videos and more.View the video of this episode on www.thermofisher.com/chemistry-podcast. A free thank you gift for our listeners! Visit the episode website and request your free Bringing Chemistry to Life t shirt.Use Podcast Code:  liV4chem in February or laBcheM in March We read every email so please share your questions and feedback with us! Email helloBCTL@thermofisher.com About Your HostPaolo Braiuca grew up in the North-East of Italy and holds a PhD in Pharmaceutical Sciences from nearby esteemed University of Trieste, Italy. He developed expertise in biocatalysis during his years of post-doctoral research in Italy and the UK, where he co-founded a startup company. With this new venture, Paolo's career shifted from R&D to business development, taking on roles in commercial, product management, and marketing. He has worked in the specialty chemicals, biotechnology, and pharmaceutical markets in Germany and the UK, where he presently resides. He is currently the Director of Global Market Development in the Laboratory Chemicals Division at Thermo Fisher Scientific™ which put him in the host chair of the Bringing Chemistry to Life podcast. A busy father of four, in what little free time he has, you'll find him inventing electronic devices with the help of his loyal 3D-printer and soldering iron. And if you ask him, he'll call himself a “maker” at heart.

Ammonia is one of the hottest innovation topics in the energy sector, but there's still doubt about its long-term role in the sustainable transition. Mike, Karthik, and Anthony are joined by Jacob Grose, CEO of Copernic, to discuss the future of low carbon ammonia and how innovation can drive decarbonization in energy and industrial applications.

Protein biology has always been grounded in the relationship between structure and function but how we determine structure has changed dramatically. While it's still common to crystallize a protein for X-ray diffraction and then back calculate its structure, supercomputing-powered, AI-driven tools have revolutionized approaches to getting a protein structure and engineer proteins for uses such as biocatalysis. Amazing right, but how? By using wet lab data to train and then compute, protein structure based on their sequence alone, which is why talking with this episode's guest is so interesting. In this episode, Dr. Ahir Pushpanath, Enzyme Technology Innovation Lead at Basecamp Research, explains his passion for gaming as the reason he got interested in this unique computational approach to chemical catalysis. He takes us through the field's fascinating history, recent breakthroughs, and their immense potential. You'll hear about the intersection of his personal mission to provoke a bio-revolution with his company's mission to combine nature and AI. Today at Basecamp Research, Ahir and his team are working to remove global bias from protein-specific AI training sets by collecting samples and data from diverse locations, but their primary focus is to understand the why of protein evolution. Ultimately, they hope to someday be able to help make a protein for every conceivable function by incorporating environmental pressure aspects into their sequence/structure/function AI models. Related episodes: S4 : E3 Chemistry, Computers, and HumansS2: E5 Questioning the limits of Moore's law Other episodes on catalysis:S3:E2 Making impossible moleculesS2:E1 Chemistry: a modern American dreamS2: E3  Rethinking catalysis Bonus content!Access bonus content curated by this episode's guest by visiting www.thermofisher.com/chemistry-podcast for links to recent publications, podcasts, books, videos and more. View the video version of this episode on www.thermofisher.com/chemistry-podcast.  A free thank you gift for our listeners! Visit the episode website and request your free Bringing Chemistry to Life t shirt. Use Podcast Code:  2023wrap in December 2023 or Ba++ery in January 2024. Share your feedback with us! Email helloBCTL@thermofisher.com About Your HostPaolo Braiuca grew up in the North-East of Italy and holds a PhD in Pharmaceutical Sciences from nearby esteemed University of Trieste, Italy. He developed expertise in biocatalysis during his years of post-doctoral research in Italy and the UK, where he co-founded a startup company. With this new venture, Paolo's career shifted from R&D to business development, taking on roles in commercial, product management, and marketing. He has worked in the specialty chemicals, biotechnology, and pharmaceutical markets in Germany and the UK, where he presently resides. He is currently the Director of Global Market Development in the Laboratory Chemicals Division at Thermo Fisher Scientific™ which put him in the host chair of the Bringing Chemistry to Life podcast. A busy father of four, in what little free time he has, you'll find him inventing electronic devices with the help of his loyal 3D-printer and soldering iron. And if you ask him, he'll call himself a “maker” at heart.

Dr. John Toussaint, Catalysis' Executive Board Chair and Steve Shortell, Co-Founder of the Center for Lean Engagement and Research (CLEAR) at the University of California – Berkley, join us to discuss the content of the article they helped write, "The Better Care Plan: A Blueprint for Improving America's Healthcare System." This article explores how to transition the current fee-for-service system in America to a risk-adjusted payment system with increased transparency on performance to continuously improve outcomes.

Pam Helander, Catalysis faculty, shares about the pilot workshop, Lean Management System in Action, that Catalysis held at Mount Sinai Morningside in New York City.

Episode 643: July 29, 2023 playlist: Blonde Redhead, "Melody Experiment" (Sit Down for Dinner) 2023 Section1 Joshua Hill and Micaela Tobin, "Fade Away" (Tent Music) 2023 Whited Sepulchre Euglossine, "Pollinator" (Bug Planet Is the Current Timeline) 2023 Hausu Mountain The Bug, "Sickness(Slowly dying)" (Machine 2) 2023 Pressure Aereogramme, "The Black Path" (Sleep and Release) 2003 Chemikal Underground Merzbow, "CATalysis No 3" (CATalysis) 2023 Elevator Bath Fugazi, "Returning the Screw" (In On the Kill Taker) 1993 Dischord Lankum, "Newcastle" (False Lankum) 2023 Rough Trade Fabiano do Nascimento, "Babel" (Das Nuvens) 2023 Leaving Drawing Virtual Gardens, "Be aware there is a goat hidden in the trees" (22:22) 2023 Lost Tribe Sound Lusine, "Zero to Sixty (ft. Sarah Jaffe)" (Long Light) 2023 Ghostly Theodore Cale Schafer, "See You Soon" (Trust) 2023 Students of Decay Email podcast at brainwashed dot com to say who you are; what you like; what you want to hear; share pictures for the podcast of where you're from, your computer or MP3 player with or without the Brainwashed Podcast Playing; and win free music! We have no tracking information, no idea who's listening to these things so the more feedback that comes in, the more frequent podcasts will come. You will not be put on any spam list and your information will remain completely private and not farmed out to a third party. Thanks for your attention and thanks for listening.

Visit https://www.thermofisher.com/chemistry-podcast/ to access the extended video version of this episode and the episode summary sheet, which contains links to recent publications and additional content recommendations for our guest. You can also access the extended video version of this episode via our YouTube channel to hear, and see, more of the conversation!Visit https://thermofisher.com/bctl and use the code PaoloRKS in July to register for your free Bringing Chemistry to Life T-shirt. Moving from a linear economy, where things are made, used and discarded, to a circular one, based on recycling and reuse, is one of the most important and difficult challenges for our society. Cracking this problem and moving to a more sustainable way of living, while maintaining or even improving living standards, is key for the future of our planet.With Matthew Liu, we go back to topics discussed in Episode 6 of Season 1 to look at one of the most important chemical elements, nitrogen. Reducing atmospheric nitrogen to nitrates is fundamental to our modern world. Nitrogen reduction makes possible to feed billions of people globally and it provides some of the most fundamental building blocks of modern chemistry. At the same time, it is one of the most energy-intense industrial processes, and its products, while essential and beneficial, eventually become environmental pollutants at the end of their lifecycle. An old technology might be the key to change this landscape. Electrochemistry is going through a renaissance and it's a very promising tool to recover nitrogen and put it back into the economic circle. In our discussion with Matthew we discuss some breakthrough and novel electrochemical approaches, electrocatalysis in particular, and how they can impact the economy of developed and under-developed countries.

Hear from Glenda Reichert, a Performance Improvement Analyst with UnityPoint Health at Trinity in Muscatine, Iowa, who has been part of the Catalysis community for many years. Glenda shares about how Trinity continues to review and apply shared learnings from Catalysis in their work.

In this interview we discuss with a leading pioneer in chemistry, Dr. L.C. Campeau, his career and his accomplishments thus far, and what has been an impetus for his achievements. Dr. L.C. Campeau is also a Fellow of the Royal Society of Canada. -- Dr. Campeau's Biography: L.-C. Campeau obtained his Ph. D. degree in 2007 with the late Professor Keith Fagnou at the University of Ottawa in Canada as an NSERC Doctoral Fellow, after completing his B.Sc. in Biopharmaceutical Sciences. He was the recipient of the Pierre Laberge Prize for the best Ph.D. thesis in the Science Faculty. The Faculty of Science awarded him the inaugural Young Alumni Award in 2016 and in 2022 he received the inaugural Department of Chemistry and Biomolecular Sciences Distinguished Alumni Award. L.-C. first joined Merck Research Laboratories at Merck-Frosst in Montreal in 2007 making key contributions to the discovery of Doravirine (MK-1439) for which he received a Merck Special Achievement Award. In 2010, he moved from Quebec to New Jersey, where he has served in roles of increasing responsibility Head of Catalysis & Automation, Head of Discovery Process Chemistry and Head of Process Chemistry. L.-C. is currently Associate Vice President and the Head of Small Molecule Process Research and Development, leading a team of smart creative scientists and engineers developing innovative solutions in support of all discovery, pre-clinical and clinical active pharmaceutical ingredient deliveries for the entire Merck portfolio for small-molecule therapeutics. Over his tenure at Merck, L.-C. and his team have made important contributions to >40 clinical candidates and 7 commercial products to date. Under his leadership, his organization has received the EPA's Green Chemistry Challenge Award four consecutive years and received the Heroes of Chemistry Award for their work on Molnupiravir in 2022. His passion for scientific excellence exemplified by >80 publications and patents, several successful collaborations with key academics, and an extensive list of >85 invited lectures worldwide. As a proud Canadian, L.-C. continues his engagement in the Canadian chemistry community, serving 4 years on the NSERC Discovery Grants committee (2019-2022) and currently sits on the NSERC National Awards Selection Committee. L.-C. was elected Fellow of the Royal Society of Canada in 2022.

In this interview we discuss with a leading pioneer in chemistry, Dr. L.C. Campeau, his career and his accomplishments thus far, and what has been an impetus for his achievements. Dr. L.C. Campeau is also a Fellow of the Royal Society of Canada. -- Dr. Campeau's Biography: L.-C. Campeau obtained his Ph. D. degree in 2007 with the late Professor Keith Fagnou at the University of Ottawa in Canada as an NSERC Doctoral Fellow, after completing his B.Sc. in Biopharmaceutical Sciences. He was the recipient of the Pierre Laberge Prize for the best Ph.D. thesis in the Science Faculty. The Faculty of Science awarded him the inaugural Young Alumni Award in 2016 and in 2022 he received the inaugural Department of Chemistry and Biomolecular Sciences Distinguished Alumni Award. L.-C. first joined Merck Research Laboratories at Merck-Frosst in Montreal in 2007 making key contributions to the discovery of Doravirine (MK-1439) for which he received a Merck Special Achievement Award. In 2010, he moved from Quebec to New Jersey, where he has served in roles of increasing responsibility Head of Catalysis & Automation, Head of Discovery Process Chemistry and Head of Process Chemistry. L.-C. is currently Associate Vice President and the Head of Small Molecule Process Research and Development, leading a team of smart creative scientists and engineers developing innovative solutions in support of all discovery, pre-clinical and clinical active pharmaceutical ingredient deliveries for the entire Merck portfolio for small-molecule therapeutics. Over his tenure at Merck, L.-C. and his team have made important contributions to >40 clinical candidates and 7 commercial products to date. Under his leadership, his organization has received the EPA's Green Chemistry Challenge Award four consecutive years and received the Heroes of Chemistry Award for their work on Molnupiravir in 2022. His passion for scientific excellence exemplified by >80 publications and patents, several successful collaborations with key academics, and an extensive list of >85 invited lectures worldwide. As a proud Canadian, L.-C. continues his engagement in the Canadian chemistry community, serving 4 years on the NSERC Discovery Grants committee (2019-2022) and currently sits on the NSERC National Awards Selection Committee. L.-C. was elected Fellow of the Royal Society of Canada in 2022.

Professor Polshettiwar is based at the Prestigious Tata Institute of Fundamental Research (TIFR) (https://www.tifr.res.in). Prof Polshettiwar was educated at a number of institutions across India, before he moved to France, the United States, and Saudi Arabia. In 2013 he joined the TIFR.Prof Vivek is a Leading researcher in a nanotechnology. He runs a nano-catalysis Laboratory in TIFR, integrated into the Division of Chemical Sciences (DCS). He uses principles of nanochemistry to make new materials which have widespread applications.Prof Vivek has published many papers in international journals. His NANOCAT group (https://www.nanocat.co.in/ ) works on CO2 capture and conversion to tackle climate change through the development of novel nanomaterials for catalysis and solar energy harvestingProf. Vivek is a Fellow of the royal society of chemistry, UK. He has been rewarded an “Asian Rising Stars” at 15th Asian Chemical Congress (ACC), Singapore, by Nobel Laureate Professor Ei-ichi Negish . He has been recently awarded the 2022 IUPAC-CHEMRAWN VII Prize for Green Chemistry in recognition of his outstanding contributions to the field of green chemistry. Terms usedIf you're not familiar with some of the terms used in this discussion – some key ones are described here for your reference:Artificial photosynthesis – A human-designed process that creates energy from Co2, water and sunlight, mimicking the same process which occurs naturally in plants.Catalysis – Increasing the rate of a chemical reaction by adding a catalyst.CO2 – Carbon Dioxide, one of the major greenhouse gases, and one of the molecules used by plants to create energy from photosynthesis.Nano chemistry – Chemical process that rely on one or more component in a particle between 1 to 100 nm in diameter.Solar photons – Particles of light emitted from the Sun.Green Hydrogen – Hydrogen (H2) gener by renewable energy sources, or using low-carbon power.Electrochemical water splitting – Splitting water molecules into component Hydrogen (H2) and Oxygen (O2) molecules by passing an electric current through the water.Silica support – A (largely) non-reactive physical support medium for less robust chemically active compounds.Urea – A chemical compound with the formula CO(NH2)2. Although useful in a wide range of industrial processes, 90% of global urea production goes into fertilizers. Our theme music is "Wholesome" by Kevin MacLeod (https://incompetech.com)Music from https://filmmusic.ioLicense: CC BY (http://creativecommons.org/licenses/by/4.0/) Connect with me (Paul) at https://www.linkedin.com/in/paulorange/H.E.L. group can be found at www.helgroup.com online,on LinkedIn at https://www.linkedin.com/company/hel-group/ on Twitter, we're @hel_group, https://twitter.com/hel_groupor search for us on Facebook

For slides and more from this webinar Presented by Dr. Lisa Yerian, Chief Improvement Officer at Cleveland Clinic As with many lean journeys, we learn first, then lead. At the Cleveland Clinic, it was the same in developing a lean community of empowered healthcare workers. Dr. Lisa Yerian will share experiences and takeaways from Cleveland Clinic's ongoing lean journey. --------------- Lisa Yerian, MD, is Chief Improvement Officer and a Gastrointestinal and Hepatobiliary Pathologist at Cleveland Clinic. Since joining the organization in 2004, she has held several pathology and health system leadership positions. In her role as Chief Improvement Officer, Dr. Yerian leads a team of improvement professionals who build an improvement culture and drive strategic improvements for patients and caregivers across Cleveland Clinic. Under her leadership, the Cleveland Clinic Improvement Model was developed, tested and refined as the roadmap for the organization to pursue a culture of improvement. The model is now used by other organizations within and beyond healthcare. She also leads Access Transformation – an enterprise effort to easily and effectively connect people with care across digital, virtual and traditional channels. Over the last decade, Dr. Yerian's team has engaged over 20,000 Cleveland Clinic caregivers in improvement by developing capability across the organization and building systems to support patients and caregivers. These initiatives include an integrated system of tiered daily huddles and an enterprise-wide improvement training program. Dr. Yerian has authored over 150 manuscripts, articles, and book chapters in the fields of pathology and improvement. Her efforts have been recognized in multiple awards, including the Association of American Medical Colleges Clinical Care Innovation Challenge Award (2016), the Smart Culture Conference Buffalo Award (2018) and the Outstanding Innovation in Delivery Solutions Award (2020). She serves on the Board of Directors for Lean Enterprise Institute and Catalysis. She speaks nationally and internationally on liver pathology and on the cultural and technical components of improvement. Dr. Yerian received a Bachelor of Science from the University of Notre Dame. She completed her medical degree, residency training in anatomic pathology and a fellowship in gastrointestinal and liver pathology at the University of Chicago-Pritzker School of Medicine.

Effective problem solving is foundational in a culture of continuous improvement. Today we are joined by Catalysis faculty member, Jenn Christison, to hear about the role collaboration plays in supporting more innovative problem solving. Jenn will delve even further into this topic during her Pre-Summit workshop “Engaging Your Teams in Collaborative Process Design” in Chicago this June. Please go to createvalue.org/summit to learn more.

Here is a quick preview of a webinar to be presented by Dr. Lisa Yerian, Chief Improvement Officer at Cleveland Clinic. Register here As with many lean journeys, we learn first, then lead. At the Cleveland Clinic, it was the same in developing a lean community of empowered healthcare workers. Dr. Lisa Yerian will share experiences and takeaways from Cleveland Clinic's ongoing lean journey. Dr. Lisa Yerian Chief Improvement Officer, Cleveland Clinic Lisa Yerian, MD, is Chief Improvement Offer and a Gastrointestinal and Hepatobiliary Pathologist at Cleveland Clinic. Since joining the organization in 2004, she has held several pathology and health system leadership positions. In her role as Chief Improvement Officer, Dr. Yerian leads a team of improvement professionals who build an improvement culture and drive strategic improvements for patients and caregivers across Cleveland Clinic. Under her leadership, the Cleveland Clinic Improvement Model was developed, tested and refined as the roadmap for the organization to pursue a culture of improvement. The model is now used by other organizations within and beyond healthcare. She also leads Access Transformation – an enterprise effort to easily and effectively connect people with care across digital, virtual and traditional channels. Over the last decade, Dr. Yerian's team has engaged over 20,000 Cleveland Clinic caregivers in improvement by developing capability across the organization and building systems to support patients and caregivers. These initiatives include an integrated system of tiered daily huddles and an enterprise-wide improvement training program. Dr. Yerian has authored over 150 manuscripts, articles, and book chapters in the fields of pathology and improvement. Her efforts have been recognized in multiple awards, including the Association of American Medical Colleges Clinical Care Innovation Challenge Award (2016), the Smart Culture Conference Buffalo Award (2018) and the Outstanding Innovation in Delivery Solutions Award (2020). She serves on the Board of Directors for Lean Enterprise Institute and Catalysis. She speaks nationally and internationally on liver pathology and on the cultural and technical components of improvement. Dr. Yerian received a Bachelor of Science from the University of Notre Dame. She completed her medical degree, residency training in anatomic pathology and a fellowship in gastrointestinal and liver pathology at the University of Chicago-Pritzker School of Medicine. Follow Dr. Yerian on Twitter: @LisaYerianMD.

We partnered with the Toyota Research Institute to take a dive into the science behind catalysis with researcher Joseph Montoya. Learn how catalytic converters drastically change the makeup of your car's exhaust and help create cleaner air for us all.   Articles:   The tough calculus of emissions and the future of EVs   MOF-derived carbonaceous materials enriched with nitrogen: Preparation and applications in adsorption and catalysis Single atom is not alone: Metal–support interactions in single-atom catalysis   This episode is sponsored by Toyota Research Institutes. Check out their homepage here. Take a look at jobs here   This episode is sponsored by Materials Today, an Elsevier community dedicated to the creation and sharing of materials science knowledge and experience through their peer-reviewed journals, academic conferences, educational webinars, and more.   Thanks to Kolobyte and Alphabot for letting us use their music in the show!   If you have questions or feedback please send us emails at materialism.podcast@gmail.com or connect with us on social media: Instagram, Twitter.   Materialism Team: Taylor Sparks (co-creator,co-host), Andrew Falkowski (co-creator,co-host) Jared Duffy (production, marketing, and editing), Ramsey Issa(editing assistance).   Keywords: Toyota Car Catalysis Catalytic Converter Smog Exhaust Platinum Nitrogen Oxide Rhodium

Date of Lecture: 11 October 2022 About the Lecture: Catalysis – the process whereby chemical reactions are accelerated by reagents that are not consumed in the reaction – is of key economic and societal importance. Catalytic technologies are vital in the production of fuels and pharmaceuticals and in a wide range of manufacturing industry; they also play a crucial role in environmental protection and remediation. Over the last thirty years the field has been transformed by the application of computational modelling and advanced characterisation techniques, with the latter increasingly employing large scale central facilities including the UK Diamond Light Source and ISIS Neutron and Muon Source. This lecture will show how fundamental science, using these techniques, undertaken by UCL scientists and others, has led to major impact in industry in the UK and worldwide. We will also discuss the future impacts of the field including its vital role in achieving the target of net zero carbon. About the Speakers: Professor Andrew Beale , Professor of Inorganic Chemistry at UCL Professor Sir Richard Catlow , Professor of Computational and Materials Chemistry at UCL

If you're not familiar with some of the terms used in this discussion – some key ones are described here for your reference:Bio-inorganic chemistry – the study of the role of metals in biological processes. This includes naturally occurring molecules and artificially introduced proteins.Metal center (active site) – the active metal in a larger molecule that reacts in (or catalyzes) a reactionCatalysis – increasing the rate of a reaction by introducing a substance to the reaction know as a catalyst. Catalysts are not consumed in the reaction.Functionalization of Carbon-Hydrogen bonds – converting a (Carbon-Hydrogen) C-H bond to a C-R bond. R represents a functional group that enables the final molecule to perform a specific reaction.Activation of Carbon-Hydrogen bonds – Reading (or breaking) the C-H bond so that the desired functional group can replace the Hydrogen.Enzyme – An organic catalyst, often found in nature and active in living cells. Enzymes are typically protein molecules.Organic molecule/organic substrate – A compound containing Carbon.Hydrogen bonding – An electrostatic force of interaction between a Hydrogen atom and another electronegative atom. The most common Hydrogen bonds occur between Hydrogen and either Nitrogen, Oxygen, or Fluorine.Reoxidize (oxidize) – during a reaction, a catalyst may accept electrons from the primary reactants or otherwise become reduced. Removing those electrons, or otherwise oxidizing the catalyst enables it to once more catalyze the reaction.Stoichiometric amount – Calculating the number of molecules (usually in moles) required for a given reaction.Photochemistry – Chemical reactions which are influenced by the presence or absence of light, often at specific wavelengths. Photochemistry is used to closely control reactions – i.e. the reaction will not take place if the correct light isn't present.Motif – A specific part of a molecule – often found in a number of molecules. Prof Maiti is contactable on social media, and you can find him on LinkedIn at https://www.linkedin.com/in/debabrata-maiti-54ab622a/ Our theme music is "Wholesome" by Kevin MacLeod (https://incompetech.com)Music from https://filmmusic.ioLicense: CC BY (http://creativecommons.org/licenses/by/4.0/) Connect with me (Paul) at https://www.linkedin.com/in/paulorange/H.E.L. group can be found at www.helgroup.com online,on LinkedIn at https://www.linkedin.com/company/hel-group/ on Twitter, we're @hel_group, https://twitter.com/hel_groupor search for us on Facebook 

Dr. Mike Conroy, Chief Medical Officer for Sutter Medical Group in Sacramento, shares how he uses leader standard work and what he has learned. Leader standard work has been a big topic of conversation throughout the Catalysis community because it helps us stay focused on what matters most.

Don Shilton, Executive Coach with Catalysis, explains how healthcare executives he is coaching have been utilizing a buddy system to help them with personal development.

Visit https://thermofisher.com/bctl to register for your free Bringing Chemistry to Life T-shirt and https://www.thermofisher.com/chemistry-podcast/ to access the extended video version of this episode and the  episode summary sheet, which contains links to recent publications and additional content recommendations for our guest. You can access the extended video version of this episode via our YouTube channel to hear, and see, more of the conversation!Entrepreneurship in the blood, a fine mind, and a bold spirit makes for a life of successes and a great podcast episode as well! This is how we would describe Chern-Hooi Lim, a Malaysian chemical engineer who is thinking big and aiming to reshape the way we make molecules through the use of light. Chern-Hooi is an expert and innovator of photocatalysis. His organo-catalysts are a big departure from the more established precious metal-based ones and bring with them the promise of a new deal for synthetic chemistry.This is a fascinating discussion about the present and future of chemistry. We discover how photocatalysis enables a new paradigm in chemistry, where we depart from fully reduced carbon sources and imitate nature in using oxidized carbon and light as the fundamental building blocks. We explore mild-condition Birch reduction, cross-coupling, and radical reactions. This is also a story of smart ideas and bold choices and a new perspective on the role entrepreneurship can play in science and technology. Another great discovery of a strong personality and the science that comes from it. more of the conversation!

Episode page: https://valuecapturellc.com/he68 Joining us today as our guest is Jeff Hunter, the President of Jeff Hunter Strategy. He is the author of Patient-Centered Strategy: A Learning System for Better Care, published by Catalysis in 2018. Jeff is on the faculty of Catalysis, and the Donald J. Schneider School of Business and Economics at St. Norbert College. From 1991 until his retirement in 2015 he was the Senior Vice President, Strategy and Marketing for ThedaCare, a healthcare system based in Appleton, Wisconsin. Jeff received his B.S. in Economics from the University of Detroit and his M.A. in Health Services Administration from the University of Wisconsin-Madison. In today's episode, Jeff talks with host Mark Graban, about topics and questions including: As we shift to a new mode of the pandemic — living with Covid — What are you hearing from healthcare leaders about what's required next? Hearing a lot of “Thank God I had the Lean management system” for the pandemic - discipline, standard work How do you define strategy? Not just a binder… Strategy plan vs. strategy? Differentiation — what differentiates us? Not imitating From budgeting to financial forecasting (beyond budgeting) Strategy plan or hypothesis? - PDSA cycles — Roadmap or GPS? Strategy formulation and strategy deployment?? Lot of choices that have to be made? How to make better choices? Better choices more quickly? How do you define a management system, a strategic management system? What makes it really work? Reinvigorating the management system, but learning from the first time Click to visit the main Habitual Excellence podcast page.

What's the background of a Noble Prize winner in chemistry, where are the next innovations in science, and how do you say “asymmetric organocatalysis”? Find out the answers on this week's episode as we chat with David MacMillan. From food production to industrial manufacturing, catalysts are all around us and play an outsized role in our lives. It's estimated that 90% of all commercially produced chemical products are reliant on catalysts at some point in the manufacturing process. Many of these reactions aren't sustainable. When studying as a post-doc at Harvard, David MacMillan had a eureka moment that led to groundbreaking research for green chemistry with his innovative organocatalysis.David also works to catalyze human connections and accelerate scientific advancement through his work at the Princeton Catalysis Initiative. His insights into catalyzing cross-field collaboration are sure to inspire!About David MacMillanDavid MacMillan is a Nobel laureate, the James S. McDonnell Distinguished University Professor of Chemistry at Princeton University, and director of the Princeton Catalysis Initiative, which accelerates research collaboration between scholars at Princeton and industry. He conceptualized and pioneered the field of asymmetric organocatalysis, and in 2021, he was named a co-recipient of the Nobel Prize in Chemistry for his work in the field.Along with numerous awards and commendations, Professor MacMillan has been elected a Fellow of the Royal Society and a member of the American Academy of Arts and Sciences.Princeton Catalysis InitiativePCI catalyzes collaborations between molecular, physical, biological, and social scientists who conduct high-impact research across disparate fields of study. By creating a new mechanism conducive to interdisciplinary research, PCI unites historically distinct areas to unleash new thinking, novel technologies, and ground-breaking applications.Links: https://chemistry.princeton.edu/faculty/david-macmillanhttps://pci.princeton.edu/https://www.nobelprize.org/prizes/chemistry/2021/macmillan/facts/https://en.wikipedia.org/wiki/OrganocatalysisQualio WebsitePrevious episodes: https://www.qualio.com/from-lab-to-launch-podcastApply to be on the show: https://forms.gle/uUH2YtCFxJHrVGeL8Music by keldez

Mike Radtke, Catalysis faculty, talks with us about effective coaching and experimentation in problem solving.

Kata is a pattern or routine that serves as a guide to proficiency and expertise. Bill Boyd, Catalysis faculty, explains the use of kata in healthcare and how it engages team members in rapid cycles of experimentation.

As your organization matures on the journey to organizational excellence the function of the improvement team evolves from project-based facilitation to supporting leaders through culture transformation. Today I am joined by Catalysis staff and faculty to discuss the importance of building coaching capability within your PI team. If you are looking to develop you coaching skills check out our virtual workshop, Building Coaching Capabilities: Transforming Your Improvement Team at createvaleu.org/coachingcapabilities or check out our full list of upcoming workshops at createvalue.org/workshops.

Visit https://thermofisher.com/bctl to register for your free Bringing Chemistry to Life T-shirt and https://www.thermofisher.com/chemistry-podcast/ to access the extended video version of this episode and the  episode summary sheet, which contains links to recent publications and additional content recommendations for our guest. You can also access the video version of this episode via https://youtu.be/LtWghIdoeLo. One of the most difficult scientific concepts to grasp is how things behave differently in the macro- vs. the nano-scale. For example, everyone knows that gold is shiny and yellow, but gold nanoparticles suspended in a liquid (colloidal gold) are red. Dr. Emilie Ringe, a Canadian-born Assistant Professor at the University of Cambridge, travelled the world investing the best part of her still young career in studying one of these intriguing phenomena. She is an expert of the so-called plasmonic nano-materials, focusing specifically on magnesium. These materials can collect specific wavelengths of light and emit energy, behaving like nano antennas.The potential applications are incredible, from an efficient way to apply localized energy to chemical reactions, to an innovative and benign cancer treatment. And in perfect Bringing Chemistry to Life style, the discovery of the science and the person go hand in hand, making for a great start of Season 3!

Dr. Dorothy Hung, Ph.D., Director of the Center for Lean Engagement & Research at the University of California - Berkley (CLEAR) joins The Lens to discuss recent research CLEAR completed through interviews with healthcare leaders on the benefits of using a Daily Management System during the pandemic. CLEAR is a partner of Catalysis in providing objective academic research in the application of Lean in Healthcare.

Aditi Patil, Catalysis faculty member, shares how to engage people through communication by using a storytelling approach. This approach is a powerful way to influence and connect people throughout an organizational transformation.

New care model development requires investment in planning for the future where care needs may look very different than they currently do to stay relevant. This week we will share an excerpt from Anita Iyenger, Chief Strategy Officer at Legacy Health, discussing her organizational and personal leadership experiences around leading and managing deep and lasting change including developing new care models. If you are interested in new care model development, Catalysis can help. We develop customized transformation roadmaps that engage all levels of the organization and help you progress your transformation journey. Learn more at createvlaue.org/transformation-roadmap.

Host: Devesh Tupkar Guest: Dr. Kevin Shaughnessy Listen to the latest podcast, where Devesh Tupkar interviews Dr. Kevin Shaughnessy. Dr. Shaughnessy talks about his current research projects and his inspirations for choosing these projects. The core topics of research performed in Dr. Shaughnessy's lab are the development of novel ligands for aqueous catalysis and structure-activity relationship for ligands. Dr. Shaughnessy received his bachelor's degree from the University of Nebraska, a Ph.D. from Stanford University, and a postdoctoral associate degree from Yale University.

Katie has spent 20 years of experience in supporting change and improvement in organizations across a range of industries, including healthcare, manufacturing, academia, biotech, government, start-ups, and business. Her professional focus since 2006 has been on leading transformational change in healthcare organizations and other industries. Prior to founding KBJ Anderson Consulting, she held a senior Lean leadership roles at the Sutter – Palo Alto Medical Foundation and Stanford Children's Health; was a Fulbright Scholar to Australia and a consultant for PwC Australia; and worked as a research analyst at the University of California, San Francisco and the University of Sydney. Katie is a faculty member of https://nam11.safelinks.protection.outlook.com/?url=https%3A%2F%2Fcreatevalue.org%2Fwho-we-are%2Ffaculty%2F&data=04%7C01%7CJake.Lancaster%40BMHCC.org%7C7c7d364046144fd7de7a08d93cb3bacd%7C2059208fff284b47971ef40dac55a264%7C0%7C0%7C637607564891170824%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&sdata=q3w0FQCQF6S9zq4Ajlhwy2vipsX4BLn7hOb5mXtZC4M%3D&reserved=0 (Catalysis) (formerly the Thedacare Center for Healthcare Value) and the https://nam11.safelinks.protection.outlook.com/?url=http%3A%2F%2Fwww.lean.org%2FWhoWeAre%2FLeanPerson.cfm%3FLeanPersonId%3D252&data=04%7C01%7CJake.Lancaster%40BMHCC.org%7C7c7d364046144fd7de7a08d93cb3bacd%7C2059208fff284b47971ef40dac55a264%7C0%7C0%7C637607564891180784%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&sdata=aRDQ3QdabpXry3vn%2FMgLGB6k%2BJfx32CSUyp3nT3YTqc%3D&reserved=0 (Lean Enterprise Institute), where she teaches coaching and problem-solving workshops. She is also coaches Master's students in the Fisher School of Business MBOE program and a facilitator for the https://nam11.safelinks.protection.outlook.com/?url=http%3A%2F%2Fwww.ame.org%2Fame-san-francisco-bay-area-consortium&data=04%7C01%7CJake.Lancaster%40BMHCC.org%7C7c7d364046144fd7de7a08d93cb3bacd%7C2059208fff284b47971ef40dac55a264%7C0%7C0%7C637607564891180784%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&sdata=X2b3rHc%2FfQ5Pm976pmIeUIP2iLgChZFvegT9bYdSeFc%3D&reserved=0 (Association for Manufacturing Excellence (AME) San Francisco Bay Area) https://nam11.safelinks.protection.outlook.com/?url=http%3A%2F%2Fwww.ame.org%2Fame-san-francisco-bay-area-consortium&data=04%7C01%7CJake.Lancaster%40BMHCC.org%7C7c7d364046144fd7de7a08d93cb3bacd%7C2059208fff284b47971ef40dac55a264%7C0%7C0%7C637607564891180784%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&sdata=X2b3rHc%2FfQ5Pm976pmIeUIP2iLgChZFvegT9bYdSeFc%3D&reserved=0 (Consortium.) Finally, she serves as a Member of the Board for the https://nam11.safelinks.protection.outlook.com/?url=http%3A%2F%2Fwww.mothersmilk.org%2F&data=04%7C01%7CJake.Lancaster%40BMHCC.org%7C7c7d364046144fd7de7a08d93cb3bacd%7C2059208fff284b47971ef40dac55a264%7C0%7C0%7C637607564891190743%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&sdata=iDVfOhgDqmuXFKWuHw9oD6ICG4XvCck8FKESorHyze0%3D&reserved=0 (Mother's Milk Bank) and a Member of the https://nam11.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.elcaminohospital.org%2Fabout-us%2Fleadership%2Fboard-committees&data=04%7C01%7CJake.Lancaster%40BMHCC.org%7C7c7d364046144fd7de7a08d93cb3bacd%7C2059208fff284b47971ef40dac55a264%7C0%7C0%7C637607564891190743%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&sdata=faiWidcPFK8MHIo4Xc29geMdZDyEhc91clTZQVYrQsM%3D&reserved=0 (Quality and Patient Experience Board Committee at El Camino Hospital). Link to claim CME credit: https://www.surveymonkey.com/r/3DXCFW3 (https://www.surveymonkey.com/r/3DXCFW3) CME credit is available for up to...

Dr. Toussaint is an internist, a former healthcare CEO, a coach, and the author of the bestseller On the Mend. Link to claim CME credit: https://www.surveymonkey.com/r/3DXCFW3 (https://www.surveymonkey.com/r/3DXCFW3) CME credit is available for up to 3 years after the stated release date Contact CEOD@bmhcc.org if you have any questions about claiming credit.

In this episode, we discuss building the foundation for lean transformation with Tom Hartman, Executive Coach at Catalysis and former senior executive at Autoliv, the world's largest manufacturer of automotive safety products. This foundation is your organization's purpose combined with principles and values and it starts at the executive level.

John Toussaint, MD, founder of Catalysis and co-author of Becoming the Change, explains why leader behaviors are fundamental to building a culture of improvement.

Dr. Eric Dickson, CEO at UMass Memorial Health Care, and John Toussaint, Executive Chairman of the Board at Catalysis. We have invited them both to help us discuss the difference between continuous improvement and new care model development. Both methodologies are important for healthcare systems to utilize in order to remain competitive and relevant in the future. "We need both evolution and revolution. Right now we have great processes for evolution – continuous improvement of a value stream, which in some cases (as John mentioned) allows us to do the wrong thing more and more efficiently over time. So we get twice as good at doing the wrong thing. Sometimes that locks you into keeping it the same way. We need good processes to look for that revolution piece – that new breakthrough. It is something that I am looking forward to learning more about overtime." - Eric Dickson

A panel of Catalysis faculty members, including Ted Toussaint, Adam Ward, and Pete Knox join us to discuss new care model development and why this thinking is the future of healthcare delivery. New care models must be designed to meet the needs of the future healthcare environment. Process improvement techniques will not make a large enough impact to meet future demands.

A recent article on HBR written by Ken Segel and John Toussaint stated that before the COVID-19 pandemic struck the US health care industry suffered more than 550,000 work-related injuries or illnesses per year. This number is significantly greater than any other industry. Healthcare leaders can prevent work-related injuries. In this episode Ken Seagel, Managing Director at Value Capture LLC, and John Toussaint, Executive Chairman of the Board at Catalysis, share five leadership imperatives to protecting healthcare workers.

Details active and allosteric site binding and distinguishes between reaction and regulation.

Catalysis faculty member and author of Patient-Centered Strategy, Jeff Hunter to discuss some of the questions that he has been hearing from healthcare leaders on how COVID-19 is and should impact their strategy deployment process.

This week's episode features Prof. Feier Hou. We talk about cats, crystals, and her academic journey from China to the USA. Prof. Hou is now in her second year at Western Oregon University, a Primarily Undergraduate Institution (PUI) - it wasn't an easy road to get there. Tune in to hear about her personal experiences and insights! And also cats. Follow Prof. Hou on Twitter at @happykitten62!